文献速递肿瘤 PET/CT神经核医学

68Ga-DOTA-Exendin-4 PET/CT 对双原发胰岛素瘤的检出效能高于 MRI:一例病例报告

68Ga-DOTA-Exendin-4 PET/CT Demonstrated a Higher Detection Efficacy for Double-Primary Insulinomas Than MRI: A Case Report.
PubMed 文献 · Clin Nucl Med · 2023-01-01

本文报告一名20岁女性,因逐渐加重的嗜睡和多次头晕5个月就诊,实验室检查示血糖下降、空腹血浆胰岛素和C肽升高。MRI发现胰尾局灶性结节,68Ga-DOTA-exendin-4 PET/CT显示胰尾2处局灶性示踪剂浓聚,其中1处与MRI所见病灶对应。切除样本免疫组化证实为双原发胰岛素瘤,68Ga-DOTA-exendin-4 PET/CT对胰尾双原发胰岛素瘤的定位和表征表现优异。

要点

  • 68Ga-DOTA-exendin-4 PET/CT在胰尾检出2处局灶性示踪剂浓聚,MRI仅发现其中1处对应的结节。
  • 切除样本免疫组化证实为双原发胰岛素瘤。
  • 68Ga-DOTA-exendin-4 PET/CT对胰尾双原发胰岛素瘤的定位和表征表现优异。

核心结论

  • 68Ga-DOTA-exendin-4 PET/CT对胰尾双原发胰岛素瘤的定位和表征表现优异,检出效能高于MRI。

研究设计与样本

  • 病例报告:1名20岁女性,因逐渐加重的嗜睡和多次头晕5个月就诊,行实验室检查、MRI、68Ga-DOTA-exendin-4 PET/CT及手术切除样本免疫组化检查。

主要发现

  • 实验室检查示血糖水平下降、空腹血浆胰岛素和C肽水平升高。
  • MRI发现胰尾一处局灶性结节。
  • 68Ga-DOTA-exendin-4 PET/CT显示胰尾2处局灶性示踪剂浓聚,其中1处与MRI所示病灶对应。
  • 切除样本免疫组化结果证实为双原发胰岛素瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We presented a 20-year-old woman with gradually increasing lethargy and multiple episodes of dizziness for 5 months. The laboratory examination revealed decreasing level of blood glucose and elevated levels of fasting plasma insulin and C-peptide. The MRI identified a focal nodule in the tail of the pancreas. 68Ga-DOTA-exendin-4 PET/CT revealed 2 intense focal tracer uptakes in the tail of the pancreas, one of which corresponded to the lesion revealed on MRI. The immunohistochemical results of resected samples confirmed the diagnosis of double-primary insulinomas. 68Ga-DOTA-exendin-4 PET/CT demonstrated excellent localization and characterization for double-primary insulinomas in the tail of the pancreas.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Qiu L, Lan L, Cai L, et al. 68Ga-DOTA-Exendin-4 PET/CT Demonstrated a Higher Detection Efficacy for Double-Primary Insulinomas Than MRI: A Case Report. Clin Nucl Med. 2023. PMID: 36723891. doi:10.1097/RLU.0000000000004508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。